InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.85
(
0.69%
)
Bitcoin
58,230.42
(
1.57%
)
Post# of 253006
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rwwine

Send PM Follow Ignore
Followers 11
Posts 883
Boards Moderated 0
Alias Born 10/27/2003

rwwine

Re: DewDiligence post# 4457

Monday, 11/01/2004 8:36:51 AM

Monday, November 01, 2004 8:36:51 AM

Post# of 253006
Another question

If the "Interim Results" at the two other dose concentrations (20 mg & 40 mg) from the 207 study (pharmacokinetic study) uncovered "some" potential safety issues related to the higher concentrations, would GENR management be required to halt the current enrollment of other PII studies?


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up